S&P 500   4,981.84 (+0.13%)
DOW   38,611.85 (+0.12%)
QQQ   424.94 (-0.56%)
AAPL   182.18 (+0.34%)
MSFT   401.15 (-0.41%)
META   467.44 (-0.81%)
GOOGL   142.61 (+1.06%)
AMZN   168.60 (+0.91%)
TSLA   194.26 (+0.26%)
NVDA   674.00 (-2.95%)
NIO   5.98 (+0.34%)
AMD   164.07 (-0.98%)
BABA   75.38 (+3.06%)
T   16.99 (+0.47%)
F   12.12 (-1.06%)
MU   81.09 (+0.47%)
CGC   3.47 (-1.98%)
GE   148.47 (-0.10%)
DIS   107.54 (-1.74%)
AMC   4.55 (-2.36%)
PFE   27.60 (+0.04%)
PYPL   57.46 (-2.00%)
XOM   104.69 (+1.89%)
S&P 500   4,981.84 (+0.13%)
DOW   38,611.85 (+0.12%)
QQQ   424.94 (-0.56%)
AAPL   182.18 (+0.34%)
MSFT   401.15 (-0.41%)
META   467.44 (-0.81%)
GOOGL   142.61 (+1.06%)
AMZN   168.60 (+0.91%)
TSLA   194.26 (+0.26%)
NVDA   674.00 (-2.95%)
NIO   5.98 (+0.34%)
AMD   164.07 (-0.98%)
BABA   75.38 (+3.06%)
T   16.99 (+0.47%)
F   12.12 (-1.06%)
MU   81.09 (+0.47%)
CGC   3.47 (-1.98%)
GE   148.47 (-0.10%)
DIS   107.54 (-1.74%)
AMC   4.55 (-2.36%)
PFE   27.60 (+0.04%)
PYPL   57.46 (-2.00%)
XOM   104.69 (+1.89%)
S&P 500   4,981.84 (+0.13%)
DOW   38,611.85 (+0.12%)
QQQ   424.94 (-0.56%)
AAPL   182.18 (+0.34%)
MSFT   401.15 (-0.41%)
META   467.44 (-0.81%)
GOOGL   142.61 (+1.06%)
AMZN   168.60 (+0.91%)
TSLA   194.26 (+0.26%)
NVDA   674.00 (-2.95%)
NIO   5.98 (+0.34%)
AMD   164.07 (-0.98%)
BABA   75.38 (+3.06%)
T   16.99 (+0.47%)
F   12.12 (-1.06%)
MU   81.09 (+0.47%)
CGC   3.47 (-1.98%)
GE   148.47 (-0.10%)
DIS   107.54 (-1.74%)
AMC   4.55 (-2.36%)
PFE   27.60 (+0.04%)
PYPL   57.46 (-2.00%)
XOM   104.69 (+1.89%)
S&P 500   4,981.84 (+0.13%)
DOW   38,611.85 (+0.12%)
QQQ   424.94 (-0.56%)
AAPL   182.18 (+0.34%)
MSFT   401.15 (-0.41%)
META   467.44 (-0.81%)
GOOGL   142.61 (+1.06%)
AMZN   168.60 (+0.91%)
TSLA   194.26 (+0.26%)
NVDA   674.00 (-2.95%)
NIO   5.98 (+0.34%)
AMD   164.07 (-0.98%)
BABA   75.38 (+3.06%)
T   16.99 (+0.47%)
F   12.12 (-1.06%)
MU   81.09 (+0.47%)
CGC   3.47 (-1.98%)
GE   148.47 (-0.10%)
DIS   107.54 (-1.74%)
AMC   4.55 (-2.36%)
PFE   27.60 (+0.04%)
PYPL   57.46 (-2.00%)
XOM   104.69 (+1.89%)

Akari Therapeutics (AKTX) News Today

$2.30
-0.09 (-3.77%)
(As of 03:43 PM ET)
SourceHeadline
MarketBeat logoAkari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com
americanbankingnews.com - February 20 at 2:42 AM
msn.com logoEuropean Equities Traded in the US as American Depositary Receipts Set to End Week Higher in Friday Trading
msn.com - February 16 at 12:18 PM
MarketBeat logoStockNews.com Initiates Coverage on Akari Therapeutics (NASDAQ:AKTX)
americanbankingnews.com - February 14 at 1:50 AM
msn.com logoPVL: Akari’s Max Juangco taking pressure of her pro debut in stride
msn.com - February 9 at 12:22 PM
msn.com logoEuropean Equities Traded in the US as American Depositary Receipts Slightly Lower in Wednesday Trading
msn.com - February 7 at 2:02 PM
msn.com logoEuropean Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading But End Week Higher
msn.com - February 2 at 2:00 PM
investing.com logoAkari Therapeutics PLC (AKTX)
investing.com - January 23 at 11:28 PM
msn.com logoPVL: Faith Nisperos, Akari Chargers aim for Final Four
msn.com - January 22 at 1:00 AM
finanznachrichten.de logoAkari Therapeutics Plc: Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing
finanznachrichten.de - January 2 at 10:30 AM
finance.yahoo.com logoAkari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing
finance.yahoo.com - January 2 at 10:30 AM
finance.yahoo.com logoAkari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing
finance.yahoo.com - January 2 at 10:30 AM
msn.com logoAkari Therapeutics Plc - ADR (AKTX) Price Target Increased by 45.45% to 81.60
msn.com - December 16 at 5:51 PM
finance.yahoo.com logoAkari Therapeutics to Present at Biotech Showcase 2024
finance.yahoo.com - December 14 at 8:44 AM
investing.com logoAkari Therapeutics (AKTX) Earnings Dates & Reports
investing.com - December 2 at 2:12 PM
msn.com logoEuropean Equities Traded in the US as American Depositary Receipts Poised to End Week Flat in Friday Trading
msn.com - December 1 at 1:33 PM
sg.finance.yahoo.com logoAkari Therapeutics, Plc (CLA.F)
sg.finance.yahoo.com - November 28 at 11:19 PM
msn.com logoEuropean Equities Traded in the US as American Depositary Receipts Climb Higher Friday
msn.com - November 24 at 12:59 PM
finance.yahoo.com logoAkari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
finance.yahoo.com - November 16 at 9:43 AM
msn.com logoTravel, Pharma Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday
msn.com - November 14 at 3:37 PM
finance.yahoo.com logoAkari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
finance.yahoo.com - November 6 at 10:25 AM
finance.yahoo.com logoPresenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now
finance.yahoo.com - October 3 at 7:28 AM
finanznachrichten.de logoAkari Therapeutics Plc: Akari Therapeutics Reports First Half 2023 Financial Results and Highlights
finanznachrichten.de - September 29 at 9:16 AM
finance.yahoo.com logoAkari Therapeutics Reports First Half 2023 Financial Results and Highlights
finance.yahoo.com - September 29 at 9:16 AM
finance.yahoo.com logoAkari Therapeutics to Present at Emerging Growth Conference
finance.yahoo.com - September 27 at 12:36 PM
finance.yahoo.com logoAkari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing, Company Also Receives $2.5 Million U.K. R&D Tax Credit
finance.yahoo.com - September 21 at 12:40 PM
finance.yahoo.com logoAkari Therapeutics to Host Key Opinion Leader Webinar on Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) and the Potential of Nomacopan to Address Significant Unmet Needs
finance.yahoo.com - September 19 at 8:13 AM
finance.yahoo.com logoAkari Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
finance.yahoo.com - September 5 at 8:27 AM
msn.com logoAkari Therapeutics Plc - ADR (AKTX) Price Target Increased by 1900.00% to 56.10
msn.com - August 31 at 7:09 PM
finance.yahoo.com logoBritish pharma opens U.S. headquarters in Boston
finance.yahoo.com - August 21 at 5:21 PM
finance.yahoo.com logoAkari Therapeutics Announces Establishment of Boston U.S. Headquarters Office to Support Expanding Operations and Start of Registrational Phase 3 Clinical Trials
finance.yahoo.com - August 18 at 8:07 AM
marketbeat.com logo
marketbeat.com - August 17 at 10:28 AM
marketbeat.com logo
marketbeat.com - August 17 at 10:14 AM
finanznachrichten.de logoAkari Therapeutics Plc: Akari Therapeutics Announces ADS Ratio Change
finanznachrichten.de - August 17 at 9:01 AM
finanznachrichten.de logoAkari Therapeutics Plc: Akari Therapeutics, Plc Announces ADS Ratio Change
finanznachrichten.de - August 15 at 3:26 PM
msn.com logoAkari Therapeutics announces ADS ratio change
msn.com - August 15 at 3:26 PM
finance.yahoo.com logoAkari Therapeutics, Plc Announces ADS Ratio Change
finance.yahoo.com - August 15 at 3:26 PM
finanznachrichten.de logoAkari Therapeutics Plc: Akari Therapeutics Announces the Appointment of Beth-Anne Lang as Senior Vice President, Regulatory Affairs
finanznachrichten.de - August 2 at 9:32 AM
finance.yahoo.com logoAkari Therapeutics Announces the Appointment of Beth-Anne Lang as Senior Vice President, Regulatory Affairs
finance.yahoo.com - August 2 at 9:32 AM
finance.yahoo.com logoAkari Therapeutics Granted Nomacopan Orphan Drug Designation from the European Commission for Treatment in Hematopoietic Stem Cell Transplantation
finance.yahoo.com - July 27 at 11:33 AM
finanznachrichten.de logoAkari Therapeutics Plc: Akari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco as Interim Chief Financial Officer
finanznachrichten.de - July 19 at 9:59 AM
finance.yahoo.com logoAkari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco as Interim Chief Financial Officer
finance.yahoo.com - July 19 at 9:59 AM
finanznachrichten.de logoAkari Therapeutics Plc: Akari Therapeutics Provides Updates on Development of Nomacopan in Pediatric and Adult HSCT-TMA
finanznachrichten.de - July 15 at 1:49 AM
finance.yahoo.com logoAkari Therapeutics Provides Updates on Development of Nomacopan in Pediatric and Adult HSCT-TMA
finance.yahoo.com - July 13 at 10:12 AM
finanznachrichten.de logoAkari Therapeutics Plc: Akari Therapeutics Provides Update on Development of Long-Acting PAS-Nomacopan for Treatment of Geographic Atrophy
finanznachrichten.de - July 11 at 9:34 AM
finance.yahoo.com logoAkari Therapeutics Provides Update on Development of Long-Acting PAS-Nomacopan for Treatment of Geographic Atrophy
finance.yahoo.com - July 11 at 9:34 AM
marketwatch.com logoAkari Therapeutics Shares Rise 22% After Nomacopan's Positive Orphan Drug Opinion in Europe
marketwatch.com - July 6 at 1:10 PM
finance.yahoo.com logoAkari Therapeutics Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Nomacopan for Treatment in Hematopoietic Stem Cell Transplantation
finance.yahoo.com - July 6 at 8:09 AM
finance.yahoo.com logoAkari Therapeutics Appoints Industry Veteran Wa’el Hashad to Board of Directors
finance.yahoo.com - July 5 at 9:59 AM
msn.com logoOil Stocks Help European Equities Move Higher Monday Trading
msn.com - June 26 at 12:28 PM
msn.com logoPharma Stocks Lead European Equities Traded as American Depositary Receipts Lower in Friday US Trading
msn.com - June 23 at 2:39 PM
Get Akari Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AKTX and its competitors with MarketBeat's FREE daily newsletter.



AKTX Media Mentions By Week

AKTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AKTX
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

AKTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AKTX Articles
This Week

2

1

AKTX Articles
Average Week

Get Akari Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AKTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AKTX) was last updated on 2/21/2024 by MarketBeat.com Staff